369 related articles for article (PubMed ID: 30344955)
1. Myocardial reperfusion injury and oxidative stress: Therapeutic opportunities.
González-Montero J; Brito R; Gajardo AI; Rodrigo R
World J Cardiol; 2018 Sep; 10(9):74-86. PubMed ID: 30344955
[TBL] [Abstract][Full Text] [Related]
2. The reduction of infarct size--forty years of research.
Ferreira R
Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
[TBL] [Abstract][Full Text] [Related]
3. Oxidative and inflammatory biomarkers of ischemia and reperfusion injuries.
Halladin NL
Dan Med J; 2015 Apr; 62(4):B5054. PubMed ID: 25872540
[TBL] [Abstract][Full Text] [Related]
4. Joint Cardioprotective Effect of Vitamin C and Other Antioxidants against Reperfusion Injury in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Rodrigo R; Prieto JC; Aguayo R; Ramos C; Puentes Á; Gajardo A; Panieri E; Rojas-Solé C; Lillo-Moya J; Saso L
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577176
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent.
Quintana M; Kahan T; Hjemdahl P
Am J Cardiovasc Drugs; 2004; 4(3):159-67. PubMed ID: 15134468
[TBL] [Abstract][Full Text] [Related]
6. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review.
Venardos KM; Perkins A; Headrick J; Kaye DM
Curr Med Chem; 2007; 14(14):1539-49. PubMed ID: 17584062
[TBL] [Abstract][Full Text] [Related]
7. Ischemia/Reperfusion Injury following Acute Myocardial Infarction: A Critical Issue for Clinicians and Forensic Pathologists.
Neri M; Riezzo I; Pascale N; Pomara C; Turillazzi E
Mediators Inflamm; 2017; 2017():7018393. PubMed ID: 28286377
[TBL] [Abstract][Full Text] [Related]
8. The Association of Ascorbic Acid, Deferoxamine and N-Acetylcysteine Improves Cardiac Fibroblast Viability and Cellular Function Associated with Tissue Repair Damaged by Simulated Ischemia/Reperfusion.
Parra-Flores P; Riquelme JA; Valenzuela-Bustamante P; Leiva-Navarrete S; Vivar R; Cayupi-Vivanco J; Castro E; Espinoza-Pérez C; Ruz-Cortés F; Pedrozo Z; Lavandero S; Rodrigo R; Diaz-Araya G
Antioxidants (Basel); 2019 Dec; 8(12):. PubMed ID: 31817022
[TBL] [Abstract][Full Text] [Related]
9. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
[TBL] [Abstract][Full Text] [Related]
10. Ischemic heart disease and antioxidants: mechanistic aspects of oxidative injury and its prevention.
Janero DR
Crit Rev Food Sci Nutr; 1995 Jan; 35(1-2):65-81. PubMed ID: 7748481
[TBL] [Abstract][Full Text] [Related]
11. Pathobiology and Clinical Impact of Reperfusion Injury.
Birnbaum Y; Leor J; Kloner RA
J Thromb Thrombolysis; 1995; 2(3):177-186. PubMed ID: 10608022
[TBL] [Abstract][Full Text] [Related]
12. Pathobiology and Clinical Impact of Reperfusion Injury.
Birnbaum Y; Leor J; Kloner RA
J Thromb Thrombolysis; 1997; 4(2):185-195. PubMed ID: 10639261
[TBL] [Abstract][Full Text] [Related]
13. Status of myocardial antioxidants in ischemia-reperfusion injury.
Dhalla NS; Elmoselhi AB; Hata T; Makino N
Cardiovasc Res; 2000 Aug; 47(3):446-56. PubMed ID: 10963718
[TBL] [Abstract][Full Text] [Related]
14. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
[TBL] [Abstract][Full Text] [Related]
15. Shenxian-Shengmai Oral Liquid Reduces Myocardial Oxidative Stress and Protects Myocardium from Ischemia-Reperfusion Injury.
Zhao Y; Zhang X; Luan J; Zhao B; An N; Sun N; Wang X; Zhao T; Sun Y; Fu ZD; Zhang Y; Zhang Y
Cell Physiol Biochem; 2018; 48(6):2503-2516. PubMed ID: 30121659
[TBL] [Abstract][Full Text] [Related]
16. Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury.
Lillo-Moya J; Rojas-Solé C; Muñoz-Salamanca D; Panieri E; Saso L; Rodrigo R
Antioxidants (Basel); 2021 Apr; 10(5):. PubMed ID: 33922912
[TBL] [Abstract][Full Text] [Related]
17. Reduced oxidative stress in STEMI patients treated by primary percutaneous coronary intervention and with antioxidant therapy: a systematic review.
Ekeløf S; Jensen SE; Rosenberg J; Gögenur I
Cardiovasc Drugs Ther; 2014 Apr; 28(2):173-81. PubMed ID: 24532094
[TBL] [Abstract][Full Text] [Related]
18. Adenosine as an Adjunct Therapy in ST Elevation Myocardial Infarction Patients: Myth or Truth?
Kassimis G; Davlouros P; Patel N; De Maria G; Kallistratos MS; Kharbanda RK; Manolis AJ; Alexopoulos D; Banning AP
Cardiovasc Drugs Ther; 2015; 29(5):481-93. PubMed ID: 26150100
[TBL] [Abstract][Full Text] [Related]
19. Dyslipidemia in Ischemia/Reperfusion Injury.
Mazo T; D'Annunzio V; Donato M; Perez V; Zaobornyj T; Gelpi RJ
Adv Exp Med Biol; 2019; 1127():117-130. PubMed ID: 31140175
[TBL] [Abstract][Full Text] [Related]
20. Effects of a novel ascorbate-based protocol on infarct size and ventricle function in acute myocardial infarction patients undergoing percutaneous coronary angioplasty.
Ramos C; Brito R; González-Montero J; Valls N; Gormaz JG; Prieto JC; Aguayo R; Puentes Á; Noriega V; Pereira G; Palavecino T; Rodrigo R
Arch Med Sci; 2017 Apr; 13(3):558-567. PubMed ID: 28507569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
